https://www.nxtpsychedelics.com/news/articles/psychedelics/awakn-life-sciences-signs-drug-development-agreement-with-catalent-for-zydisr-technology-to-conduct-feasibility-studies-to-improve-differentiation-of-its-mdma-program/